-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Ελλάδα
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Our Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
White Paper
Accelerating Patient Access to Precision Oncology in Asia-Pacific
Feb 05, 2021
The APAC region holds a diverse Health Technology Assessment (HTA) and pricing and reimbursement landscape. Current HTA approaches and economic evaluation methods may not fully capture the value of precision oncology, leading to delayed access to these innovative technologies. In collaboration with Roche, IQVIA developed a framework to characterize the market access ecosystem and state of adoption of precision oncology in APAC. Comprehensive genomic profiling and tumor-agnostic therapies were used as prime examples of precision oncology innovations. This paper reviews the varied HTA and pricing and reimbursement landscape in APAC, as well as discusses the challenges, opportunities and recommendations for sustainable access to precision oncology in the region.
Authors
- Sirinthip Petcharapiruch, MSc, Principal, Real World Solutions, IQVIA, Asia Pacific
- Junice Ng, PhD, Consultant, Real World Solutions, IQVIA, Asia Pacific
- Eemin tan, PhD, Associate Consultant, Real World Solutions, IQVIA, Asia Pacific